Search Results - "HANSEN, J. Bondo"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1
  2. 2

    Inhibition of insulin secretion as a new drug target in the treatment of metabolic disorders by Hansen, J Bondo, Arkhammar, Per O G, Bodvarsdottir, Thora B, Wahl, Philip

    Published in Current medicinal chemistry (01-06-2004)
    “…The pattern of insulin release is crucial for regulation of glucose and lipid haemostasis. Deficient insulin release causes hyperglycemia and diabetes, whereas…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Openers of ATP-dependent K+-channels protect against a signal-transduction-linked and not freely reversible defect of insulin secretion in a rat islet transplantation model of Type 2 diabetes by BJÖRKLUND, A, HANSEN, J. Bondo, FALKMER, S, GRILL, V

    Published in Diabetologia (01-05-2004)
    “…We tested whether chronic overstimulation by levels of hyperglycaemia commonly found in Type 2 diabetes can irreversibly desensitise beta cells and, if so,…”
    Get full text
    Journal Article
  5. 5

    A potent diazoxide analogue activating ATP-sensitive K+ channels and inhibiting insulin release by LEBRUN, P, ARKHAMMAR, P, ANTOINE, M.-H, NGUYEN, Q.-A, HANSEN, J. B, PIROTTE, B

    Published in Diabetologia (01-06-2000)
    “…To characterise the effects of BPDZ 73 (7-chloro-3-isopropylamino-4H-1,2,4-benzothiadiazine 1,1-dioxide), a newly synthesised diazoxide analogue, on insulin…”
    Get full text
    Journal Article Web Resource
  6. 6

    Selective blockade of T-type Ca2+ channels suppresses human breast cancer cell proliferation by Taylor, James T, Huang, Luping, Pottle, Jonathan E, Liu, Kai, Yang, Yali, Zeng, Xiangbin, Keyser, Brian M, Agrawal, Krishna C, Hansen, J. Bondo, Li, Ming

    Published in Cancer letters (18-08-2008)
    “…Abstract We have measured the expression of T-type Ca2+ channel mRNA in breast cancer cell lines (MCF-7 (ERα+) using Western blot and quantitative real-time…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Towards selective antagonists of T-type calcium channels: design, characterization and potential applications of NNC 55-0396 by Li, Ming, Hansen, J Bondo, Huang, Luping, Keyser, Brian M, Taylor, James T

    Published in Cardiovascular drug reviews (01-06-2005)
    “…NNC 55-0396 is a structural analog of mibefradil (Ro 40-5967) that inhibits both T-type and high-voltage-activated (HVA) Ca2+ channels with a higher…”
    Get more information
    Journal Article
  10. 10

    Potent and selective activation of the pancreatic beta-cell type KATP channel by two novel diazoxide analogues by DABROWSKI, M, LARSEN, T, ASHCROFT, F. M, HANSEN, J. Bondo, WAHL, P

    Published in Diabetologia (01-10-2003)
    “…We investigated the pharmacological properties of two novel ATP sensitive potassium (K(ATP)) channel openers, 6-Chloro-3-isopropylamino-4 H-thieno[3,2-…”
    Get full text
    Journal Article
  11. 11

    Alkoxyfurocoumarin derivatives as potential mesolimbic selective antipsychotics by Bondo Hansen, J, Fink-Jensen, A, Hansen, L, Nielsen, EB, Scheideler, MA

    “…A series of potential antipsychotic compounds have been synthesized by combining a furocoumarin heterocycle through a linker of different sizes with an…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Selective blockade of T-type Ca 2+ channels suppresses human breast cancer cell proliferation by Taylor, James T., Huang, Luping, Pottle, Jonathan E., Liu, Kai, Yang, Yali, Zeng, Xiangbin, Keyser, Brian M., Agrawal, Krishna C., Hansen, J. Bondo, Li, Ming

    Published in Cancer letters (2008)
    “…We have measured the expression of T-type Ca 2+ channel mRNA in breast cancer cell lines (MCF-7 (ERα+) using Western blot and quantitative real-time PCR…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Potent and selective activation of the pancreatic beta-cell type K(ATP) channel by two novel diazoxide analogues by Dabrowski, M, Larsen, T, Ashcroft, F M, Bondo Hansen, J, Wahl, P

    Published in Diabetologia (01-10-2003)
    “…We investigated the pharmacological properties of two novel ATP sensitive potassium (K(ATP)) channel openers, 6-Chloro-3-isopropylamino-4 H-thieno[3,2-…”
    Get full text
    Journal Article
  16. 16

    Protection of rat pancreatic islets by potassium channel openers against alloxan, sodium nitroprusside and interleukin-1beta mediated suppression--possible involvement of the mitochondrial membrane potential by Kullin, M, Li, Z, Bondo Hansen, J, Welsh, N, Karlsson, F A, Sandler, S

    Published in Diabetologia (01-01-2003)
    “…We aimed to study the effects of two K(ATP) channel openers (KCO), diazoxide and the more potent compound NNC 55-0118, on beta-cell suppression and/or toxicity…”
    Get full text
    Journal Article
  17. 17

    Protection of rat pancreatic islets by potassium channel openers against alloxan, sodium nitroprusside and interleukin-1[beta] mediated suppression--possible involvement of the mitochondrial membrane potential by Kullin, M, Z. Li, Hansen, J Bondo, Welsh, N, Karlsson, F A, Sandler, S

    Published in Diabetologia (01-01-2003)
    “…Aims/hypothesis. We aimed to study the effects of two KATP channel openers (KCO), diazoxide and the more potent compound NNC 55-0118, on beta-cell suppression…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Phenylcyanoguanidines as inhibitors of glucose-induced insulin secretion from beta cells by Tagmose, Tina M, Mogensen, John P, Agerholm, Pia C, Arkhammar, Per O.G, Wahl, Philip, Worsaae, Anne, Hansen, J.Bondo

    Published in Bioorganic & medicinal chemistry letters (09-07-2001)
    “…3,5-Disubstituted-phenylcyanoguanidines have been identified as activators of SUR1/Kir6.2 potassium channels and as potent inhibitors of insulin release from…”
    Get full text
    Journal Article
  20. 20